Association of high-risk stigmata and worrisome features with advanced neoplasia in intraductal papillary mucinous neoplasms (IPMN): A systematic review-Reference-Cited by-同舟云学术

Association of high-risk stigmata and worrisome features with advanced neoplasia in intraductal papillary mucinous neoplasms (IPMN): A systematic review

Published:2024-02 Issue:1 Volume:24 Page:48-61
ISSN:1424-3903
Container-title:Pancreatology
language:en
Short-container-title:Pancreatology

Author:

Ohno Eizaburo^ORCID,Balduzzi Alberto^ORCID,Hijioka Susumu^ORCID,De Pastena Matteo^ORCID,Marchegiani Giovanni,Kato Hironari^ORCID,Takenaka Mamoru^ORCID,Haba Shin^ORCID,Salvia Roberto^ORCID

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Endocrinology, Diabetes and Metabolism

Reference150 articles.

1. Long-Term outcomes and risk of pancreatic cancer in intraductal papillary mucinous neoplasms;de la Fuente;JAMA Netw Open,2023

2. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas;Tanaka;Pancreatology,2006

3. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas;Tanaka;Pancreatology,2017

4. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas;Tanaka;Pancreatology,2012

5. What is the incidence of malignancy in resected intraductal papillary mucinous neoplasms? An analysis of over 100 US institutions in a single Year;Khoury;Ann Surg Oncol,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostics and Management of Pancreatic Cystic Lesions—New Techniques and Guidelines;Journal of Clinical Medicine;2024-08-08

2. Current status of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms;DEN Open;2024-07-21

3. Navigating Intraductal Papillary Mucinous Neoplasm Management through Fukuoka Consensus vs. European Evidence-Based Guidelines on Pancreatic Cystic Neoplasms—A Study on Two European Centers;Cancers;2024-06-06

4. The Revised Kyoto Criteria and Risk of Malignancy Among Patients With Intraductal Papillary Mucinous Neoplasms;Clinical Gastroenterology and Hepatology;2024-06

5. International Evidence-based Kyoto Guidelines for the Management of Intraductal Papillary Mucinous Neoplasm of the Pancreas;The Korean Journal of Gastroenterology;2024-05-25